ADMA Biologics, Inc. (ADMA)
NASDAQ·Healthcare·Biotechnology
$10.85
-0.78%
Mkt Cap $2.57B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 25, 2026 | $139.60M | $139.16M | -0.31% | $0.18 | $0.20 | +8.11% | — | — |
| Q4 2025 Nov 5, 2025 | $139.80M | $134.22M | -3.99% | $0.16 | $0.16 | +0.00% | — | — |
| Q3 2025 Aug 6, 2025 | $130.30M | $121.98M | -6.38% | $0.14 | $0.15 | +7.14% | — | — |
| Q2 2025 May 7, 2025 | $121.80M | $114.80M | -5.75% | $0.16 | $0.14 | -12.50% | — | — |
| Q1 2025 Mar 3, 2025 | $108.65M | $117.55M | +8.19% | $0.15 | $0.14 | -6.67% | — | — |
| Q4 2024 Nov 7, 2024 | $113.40M | $119.84M | +5.68% | $0.13 | $0.15 | +15.38% | — | — |
| Q3 2024 Aug 8, 2024 | $86.41M | $107.19M | +24.05% | $0.08 | $0.13 | +62.50% | — | — |
| Q2 2024 May 9, 2024 | $77.27M | $81.88M | +5.96% | $0.06 | $0.08 | +33.33% | — | — |
| Q1 2024 Feb 28, 2024 | $72.15M | $73.90M | +2.43% | -$0.01 | $0.04 | +420.00% | — | — |
| Q4 2023 Nov 8, 2023 | $68.49M | $67.27M | -1.77% | $0.00 | $0.01 | +233.33% | — | — |
| Q3 2023 Aug 9, 2023 | $55.50M | $60.12M | +8.33% | -$0.02 | -$0.02 | -19.98% | — | — |
| Q2 2023 May 10, 2023 | $53.41M | $56.91M | +6.56% | -$0.05 | -$0.03 | +40.00% | — | — |
| Q1 2023 Mar 23, 2023 | $45.93M | $49.98M | +8.82% | -$0.07 | -$0.06 | +14.29% | — | — |
| Q4 2022 Nov 9, 2022 | $34.48M | $41.09M | +19.16% | -$0.08 | -$0.08 | +0.00% | — | — |
| Q3 2022 Aug 10, 2022 | $31.81M | $33.91M | +6.58% | -$0.09 | -$0.07 | +22.22% | — | — |
| Q2 2022 May 11, 2022 | $25.90M | $29.10M | +12.37% | -$0.08 | -$0.10 | -25.00% | — | — |
| Q1 2022 Mar 24, 2022 | $21.76M | $26.38M | +21.26% | -$0.10 | -$0.09 | +10.00% | — | — |
| Q4 2021 Nov 10, 2021 | $23.44M | $20.68M | -11.76% | -$0.15 | -$0.13 | +13.33% | — | — |
| Q3 2021 Aug 11, 2021 | $17.83M | $17.83M | -0.00% | -$0.15 | -$0.15 | +0.00% | — | — |
| Q2 2021 May 12, 2021 | $14.55M | $16.05M | +10.30% | -$0.17 | -$0.16 | +5.88% | — | — |